Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Sep;88(3):847–854. doi: 10.1172/JCI115386

Localization of human platelet autoantigens to the cysteine-rich region of glycoprotein IIIa.

R Kekomaki 1, B Dawson 1, J McFarland 1, T J Kunicki 1
PMCID: PMC295471  PMID: 1715887

Abstract

The object of this study was to further localize autoantigenic structures on IIb-IIIa and, if possible, to precisely identify the epitopes recognized by human autoantibodies. In this paper, we identify a 50-kD chymotryptic fragment of IIIa that is recognized by a high percentage of human autoantibodies, typified by the prototype IgG autoantibody RA, which binds to IIIa on intact platelets as well as in an immunoblot assay under nonreduced conditions. Using an immunoblot assay, a carboxy-terminal region of this fragment (33 kD) that contains the cysteine-rich domains of IIIa was found to carry the epitope(s) recognized by the prototype autoantibody RA. The amino-terminal amino acid sequence of the reduced 33-kD fragment, the smallest fragment that retains the RA epitope, is XPSQQDEXSP, and that of the reduced 50-kD fragment is IVQVTFD. This indicates that the 33-kD fragment consists of approximately 175 amino acids beginning at residue 479 and extending at least through residues 636-654, while the 50-kD fragment spans the same region but begins at residue 427. It is apparent that the 33-kD fragment is generated from the 50-kD fragment by additional chymotryptic hydrolysis but remains associated because of the multiple disulfide bonds that are characteristic of this cysteine-rich domain. Sera from 48% of patients with chronic ITP and 2 of 8 patients with acute ITP contain antibodies that bind to the 50-kD fragment in an ELISA. Antibodies of the same specificity are also found in one-third of patients with either secondary immune thrombocytopenia or apparent non-immune thrombocytopenia. We conclude that the 50-kD cysteine-rich region of IIIa is a frequent target of autoantibodies in ITP, but that such antibodies may also be present in cases of thrombocytopenia that cannot be linked to an apparent autoimmune process.

Full text

PDF
847

Images in this article

849Image
on p.849
850Image
on p.850
850Image
on p.850
850Image
on p.850
850Image
on p.850
850Image
on p.850

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balduini C. L., Grignani G., Sinigaglia F., Bisio A., Pacchiarini L., Rota Scalabrini D., Balduini C., Mauri C., Ascari E. Severe platelet dysfunction in a patient with autoantibodies against membrane glycoproteins IIb-IIIa. Haemostasis. 1987;17(1-2):98–104. doi: 10.1159/000215564. [DOI] [PubMed] [Google Scholar]
  2. Beardsley D. S., Spiegel J. E., Jacobs M. M., Handin R. I., Lux S. E., 4th Platelet membrane glycoprotein IIIa contains target antigens that bind anti-platelet antibodies in immune thrombocytopenias. J Clin Invest. 1984 Nov;74(5):1701–1707. doi: 10.1172/JCI111587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beer J., Coller B. S. Evidence that platelet glycoprotein IIIa has a large disulfide-bonded loop that is susceptible to proteolytic cleavage. J Biol Chem. 1989 Oct 15;264(29):17564–17573. [PubMed] [Google Scholar]
  4. Berchtold P., McMillan R., Tani P., Sommerville-Nielsen S., Blanchette V. S. Autoantibodies against platelet membrane glycoproteins in children with acute and chronic immune thrombocytopenic purpura. Blood. 1989 Oct;74(5):1600–1602. [PubMed] [Google Scholar]
  5. Boizard B., Wautier J. L. Lek a, a new platelet antigen absent in Glanzmann's thrombasthenia. Vox Sang. 1984;46(1):47–54. doi: 10.1111/j.1423-0410.1984.tb00047.x. [DOI] [PubMed] [Google Scholar]
  6. Calvete J. J., McGregor J. L., Rivas G., González-Rodríguez J. Identification of a glycoprotein III a dimer in polyacrylamide gel separations of human platelet membranes. Thromb Haemost. 1987 Aug 4;58(2):694–697. [PubMed] [Google Scholar]
  7. Chou P. Y., Fasman G. D. Prediction of beta-turns. Biophys J. 1979 Jun;26(3):367–383. doi: 10.1016/S0006-3495(79)85259-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fitzgerald L. A., Leung B., Phillips D. R. A method for purifying the platelet membrane glycoprotein IIb-IIIa complex. Anal Biochem. 1985 Nov 15;151(1):169–177. doi: 10.1016/0003-2697(85)90067-3. [DOI] [PubMed] [Google Scholar]
  9. Fitzgerald L. A., Steiner B., Rall S. C., Jr, Lo S. S., Phillips D. R. Protein sequence of endothelial glycoprotein IIIa derived from a cDNA clone. Identity with platelet glycoprotein IIIa and similarity to "integrin". J Biol Chem. 1987 Mar 25;262(9):3936–3939. [PubMed] [Google Scholar]
  10. Furihata K., Hunter J., Aster R. H., Koewing G. R., Shulman N. P., Kunicki T. J. Human anti-PlE1 antibody recognizes epitopes associated with the alpha subunit of platelet glycoprotein Ib. Br J Haematol. 1988 Jan;68(1):103–110. doi: 10.1111/j.1365-2141.1988.tb04186.x. [DOI] [PubMed] [Google Scholar]
  11. Furihata K., Nugent D. J., Bissonette A., Aster R. H., Kunicki T. J. On the association of the platelet-specific alloantigen, Pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa. J Clin Invest. 1987 Dec;80(6):1624–1630. doi: 10.1172/JCI113250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Garnier J., Osguthorpe D. J., Robson B. Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol. 1978 Mar 25;120(1):97–120. doi: 10.1016/0022-2836(78)90297-8. [DOI] [PubMed] [Google Scholar]
  13. George J. N. Studies on platelet plasma membranes. IV. Quantitative analysis of platelet membrane glycoproteins by (125I)-diazotized diiodosulfanilic acid labeling and SDS-polyacrylamide gel electrophoresis. J Lab Clin Med. 1978 Sep;92(3):430–446. [PubMed] [Google Scholar]
  14. Hopp T. P., Woods K. R. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3824–3828. doi: 10.1073/pnas.78.6.3824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kiefel V., Santoso S., Weisheit M., Müeller-Eckhardt C. Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood. 1987 Dec;70(6):1722–1726. [PubMed] [Google Scholar]
  16. Kieffer N., Boizard B., Didry D., Wautier J. L., Nurden A. T. Immunochemical characterization of the platelet-specific alloantigen Leka: a comparative study with the PlA1 alloantigen. Blood. 1984 Dec;64(6):1212–1219. [PubMed] [Google Scholar]
  17. Kornecki E., Chung S. Y., Holt J. C., Cierniewski C. S., Tuszynski G. P., Niewiarowski S. Identification of PlAl alloantigen domain on a 66 kDa protein derived from glycoprotein IIIa of human platelets. Biochim Biophys Acta. 1985 Sep 10;818(3):285–290. doi: 10.1016/0005-2736(85)90001-x. [DOI] [PubMed] [Google Scholar]
  18. Kunicki T. J., Aster R. H. Deletion of the platelet-specific alloantigen PlA1 from platelets in Glanzmann's thrombasthenia. J Clin Invest. 1978 May;61(5):1225–1231. doi: 10.1172/JCI109038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kunicki T. J., Aster R. H. Isolation and immunologic characterization of the human platelet alloantigen, P1A1. Mol Immunol. 1979 Jun;16(6):353–360. doi: 10.1016/0161-5890(79)90100-7. [DOI] [PubMed] [Google Scholar]
  20. Kunicki T. J., Newman P. J., Amrani D. L., Mosesson M. W. Human platelet fibrinogen: purification and hemostatic properties. Blood. 1985 Oct;66(4):808–815. [PubMed] [Google Scholar]
  21. Kyte J., Doolittle R. F. A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982 May 5;157(1):105–132. doi: 10.1016/0022-2836(82)90515-0. [DOI] [PubMed] [Google Scholar]
  22. Markwell M. A., Haas S. M., Bieber L. L., Tolbert N. E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978 Jun 15;87(1):206–210. doi: 10.1016/0003-2697(78)90586-9. [DOI] [PubMed] [Google Scholar]
  23. McMillan R., Tani P., Millard F., Berchtold P., Renshaw L., Woods V. L., Jr Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood. 1987 Oct;70(4):1040–1045. [PubMed] [Google Scholar]
  24. Niessner H., Clemetson K. J., Panzer S., Mueller-Eckhardt C., Santoso S., Bettelheim P. Acquired thrombasthenia due to GPIIb/IIIa-specific platelet autoantibodies. Blood. 1986 Aug;68(2):571–576. [PubMed] [Google Scholar]
  25. Niewiarowski S., Norton K. J., Eckardt A., Lukasiewicz H., Holt J. C., Kornecki E. Structural and functional characterization of major platelet membrane components derived by limited proteolysis of glycoprotein IIIa. Biochim Biophys Acta. 1989 Jul 24;983(1):91–99. doi: 10.1016/0005-2736(89)90384-2. [DOI] [PubMed] [Google Scholar]
  26. Nugent D. J., Kunicki T. J., Berglund C., Bernstein I. D. A human monoclonal autoantibody recognizes a neoantigen on glycoprotein IIIa expressed on stored and activated platelets. Blood. 1987 Jul;70(1):16–22. [PubMed] [Google Scholar]
  27. Nurden A. T., Caen J. P. An abnormal platelet glycoprotein pattern in three cases of Glanzmann's thrombasthenia. Br J Haematol. 1974 Oct;28(2):253–260. doi: 10.1111/j.1365-2141.1974.tb06660.x. [DOI] [PubMed] [Google Scholar]
  28. Phillips D. R., Agin P. P. Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins. J Clin Invest. 1977 Sep;60(3):535–545. doi: 10.1172/JCI108805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pidard D., Montgomery R. R., Bennett J. S., Kunicki T. J. Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets. J Biol Chem. 1983 Oct 25;258(20):12582–12586. [PubMed] [Google Scholar]
  30. Shibata Y., Miyaji T., Ichikawa Y., Matsuda I. A new platelet antigen system, Yuka/Yukb. Vox Sang. 1986;51(4):334–336. doi: 10.1111/j.1423-0410.1986.tb01980.x. [DOI] [PubMed] [Google Scholar]
  31. Tomiyama Y., Kurata Y., Shibata Y., Honda S., Furubayashi T., Mizutani H., Tsubakio T., Yonezawa T., Tarui S. Immunochemical characterization of an autoantigen on platelet glycoprotein IIb in chronic ITP: comparison with the Baka alloantigen. Br J Haematol. 1989 Jan;71(1):77–83. doi: 10.1111/j.1365-2141.1989.tb06278.x. [DOI] [PubMed] [Google Scholar]
  32. Tsubakio T., Tani P., Woods V. L., Jr, McMillan R. Autoantibodies against platelet GPIIb/IIIa in chronic ITP react with different epitopes. Br J Haematol. 1987 Nov;67(3):345–348. doi: 10.1111/j.1365-2141.1987.tb02355.x. [DOI] [PubMed] [Google Scholar]
  33. Woods V. L., Jr, Oh E. H., Mason D., McMillan R. Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP. Blood. 1984 Feb;63(2):368–375. [PubMed] [Google Scholar]
  34. van Leeuwen E. F., van der Ven J. T., Engelfriet C. P., von dem Borne A. E. Specificity of autoantibodies in autoimmune thrombocytopenia. Blood. 1982 Jan;59(1):23–26. [PubMed] [Google Scholar]
  35. van Leeuwen E. F., von dem Borne A. E., von Riesz L. E., Nijenhuis L. E., Engelfriet C. P. Absence of platelet-specific alloantigens in Glanzmann's thrombasthenia. Blood. 1981 Jan;57(1):49–54. [PubMed] [Google Scholar]
  36. von dem Borne A. E., von Riesz E., Verheugt F. W., ten Cate J. W., Koppe J. G., Engelfriet C. P., Nijenhuis L. E. Baka, a new platelet-specific antigen involved in neonatal allo-immune thrombocytopenia. Vox Sang. 1980 Aug;39(2):113–120. doi: 10.1111/j.1423-0410.1980.tb01845.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES